Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Tamio Teramoto
Based on 22 articles published since 2007
||||
Expertise Level
The expertise of Tamio Teramoto ranks in the
  • Top 0.12%
  • ... of 30,216 published authors worldwide on Hypercholesterolemia
  • ... from 2007 through 2018
  • ... based on contributions to 22 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Teikyo University      
2017
  • Teikyo Academic Research Center, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, Japan. Electronic address: · Department of Cardiovascular Medicine, School of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo, Japan. · Division of Anti-aging and Vascular Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa-city, Saitama, Japan. · National Center of Geriatrics and Gerontology, 7-430 Morioka-cho, Obu City, Aichi, Japan. · MSD K.K, Kitanomaru Square, 1-13-12 Kudan-kita, Chiyoda-ku, Tokyo, Japan. · MSD K.K, Kitanomaru Square, 1-13-12 Kudan-kita, Chiyoda-ku, Tokyo, Japan; Nippon Boehringer Ingelheim Co. Ltd, 2-1-1 Osaki, Shinagawa-ku, Tokyo, Japan. · Merck & Co., Inc., Kenilworth, NJ, USA. · Pubmed 28478132
  • Teikyo Academic Research Center, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan. · Asia Pacific Development, R&D, Sanofi, Tokyo, Japan. · Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. · Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan. · Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University, Iwate, Japan. · Sanofi Japan, Tokyo, Japan. · PCSK9 Development and Launch Unit, Sanofi, Montpellier, France. · Department of Cardiovascular Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan. · Pubmed 28623954
2012
  • Teikyo University School of Medicine, Department of Internal Medicine, 2-11-1 Kaga Itabashi-ku, Tokyo 173-8605, Japan. · Pubmed 22332608
2011
  • Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 21921414
2010
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 20201733
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 20543522
2009
  • Department of Internal Medicine, Teikyo University School of Medicine, Japan. · Pubmed 19907105
2008
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 18762707
Probable:    Miscellaneous institutions in Tokyo      
2016
  • Teikyo Academic Research Center, Tokyo, Japan. Electronic address: · Therapeutic Strategy Unit, Asia Pacific R&D, Sanofi, Tokyo, Japan. · Primary and Consumer Health Care Medical, Medical Operations, Sanofi, Tokyo, Japan. · Biostatistics, Biostatistics and Programming, Clinical Sciences and Operations, R&D, Sanofi, Tokyo, Japan. · Heishinkai Medical Group Incorporated ToCROM Clinic, Tokyo, Japan. · Koganeibashi Sakura Clinic, Tokyo, Japan. · Heishinaki Medical Group Incorporated OCROM Clinic, Osaka, Japan. · Daiwa Hospital, Osaka, Japan. · PCSK9 Development and Launch Unit, Sanofi, Montpellier, France. · Pubmed 27184170
2011
2008
  • Occupational Health Department, Sony Corporation, Tokyo, Japan. · Pubmed 18756039
Probable:    University of Tokyo      
2012
  • Teikyo University School of Medicine, Department of Internal Medicine, 2-11-1 Kaga Itabashi-ku, Tokyo 173-8605, Japan. · Pubmed 22332608
2011
  • Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 21921414
2010
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 20201733
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 20543522
2008
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 18762707
2009
  • Department of Neurology, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. · Pubmed 19423132
2008
  • Department of Internal Medicine, Jikei University School of Medicine 3-25-8, Nishi-Shimbashi, Minato-ku, 105-8461 Tokyo, Japan. · Pubmed 18635188
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 22 total) written by Tamio Teramoto about Hypercholesterolemia:

  • Efficacy and Safety of Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib Administered as Monotherapy in Japanese Patients With Primary Hypercholesterolemia. 2017
  • Lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in Japanese patients with dyslipidemia. 2017
  • One-Year Efficacy and Safety of Evolocumab in Japanese Patients - A Pooled Analysis From the Open-Label Extension OSLER Studies. 2017
  • Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale. 2017
  • Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive - Results From a Randomized, Placebo-Controlled, Dose-Ranging Study. 2017
  • Efficacy and Safety of Alirocumab in Japanese Subjects (Phase 1 and 2 Studies). 2016
  • Effects of evolocumab (AMG 145), a monoclonal antibody to PCSK9, in hypercholesterolemic, statin-treated Japanese patients at high cardiovascular risk--primary results from the phase 2 YUKAWA study. 2014
  • The relationship between low-density lipoprotein cholesterol levels and the incidence of cardiovascular disease in high-risk patients treated with pravastatin: main results of the APPROACH-J study. 2014
  • The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C. 2012
  • Usefulness of LDL-C-related parameters to predict cardiovascular risk and effect of pravastatin in mild-to-moderate hypercholesterolemia. 2012
Show List of Full Article Records
Google Searches

Learn more about Tamio Teramoto using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Teikyo University
Miscellaneous institutions in Tokyo
University of Tokyo
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Teikyo University
2017
  • Teikyo Academic Research Center, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, Japan. Electronic address: · Department of Cardiovascular Medicine, School of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo, Japan. · Division of Anti-aging and Vascular Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa-city, Saitama, Japan. · National Center of Geriatrics and Gerontology, 7-430 Morioka-cho, Obu City, Aichi, Japan. · MSD K.K, Kitanomaru Square, 1-13-12 Kudan-kita, Chiyoda-ku, Tokyo, Japan. · MSD K.K, Kitanomaru Square, 1-13-12 Kudan-kita, Chiyoda-ku, Tokyo, Japan; Nippon Boehringer Ingelheim Co. Ltd, 2-1-1 Osaki, Shinagawa-ku, Tokyo, Japan. · Merck & Co., Inc., Kenilworth, NJ, USA. · Pubmed 28478132
  • Teikyo Academic Research Center, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan. · Asia Pacific Development, R&D, Sanofi, Tokyo, Japan. · Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. · Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan. · Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University, Iwate, Japan. · Sanofi Japan, Tokyo, Japan. · PCSK9 Development and Launch Unit, Sanofi, Montpellier, France. · Department of Cardiovascular Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan. · Pubmed 28623954
2012
  • Teikyo University School of Medicine, Department of Internal Medicine, 2-11-1 Kaga Itabashi-ku, Tokyo 173-8605, Japan. · Pubmed 22332608
2011
  • Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 21921414
2010
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 20201733
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 20543522
2009
  • Department of Internal Medicine, Teikyo University School of Medicine, Japan. · Pubmed 19907105
2008
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 18762707
Unspecified
2017
  • Teikyo Academic Research Center, Teikyo University. · Tokyo-Eki Center-Building Clinic. · Department of Cardiovascular Medicine, University of Tokyo Hospital. · Eli Lilly Japan K.K. · Eli Lilly and Company. · Pubmed 28652529
  • Division of Cardiology, Department of Medicine, Nihon University School of Medicine. · Departments of Community Medicine and Cardiovascular Medicine, Osaka University Graduate School of Medicine. · Rinku General Medical Center. · Amgen Astellas BioPharma K.K. · Amgen Inc. · Life Science and Bioethics Research Center, Tokyo Medical and Dental University. · Department of Cardiovascular Medicine, The University of Tokyo Hospital. · Teikyo Academic Research Center, Teikyo University. · Pubmed 28367845
  • Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine. · Heishinkai Medical Group Incorporated. · ToCROM Clinic, Heishinkai Medical Group Incorporated. · Sekino Hospital. · Development Japan, Pfizer Japan Inc. · Worldwide Research and Development, Pfizer Ltd. · Teikyo Academic Research Center, Teikyo University. · Pubmed 28539539
Miscellaneous institutions in Tokyo
2016
  • Teikyo Academic Research Center, Tokyo, Japan. Electronic address: · Therapeutic Strategy Unit, Asia Pacific R&D, Sanofi, Tokyo, Japan. · Primary and Consumer Health Care Medical, Medical Operations, Sanofi, Tokyo, Japan. · Biostatistics, Biostatistics and Programming, Clinical Sciences and Operations, R&D, Sanofi, Tokyo, Japan. · Heishinkai Medical Group Incorporated ToCROM Clinic, Tokyo, Japan. · Koganeibashi Sakura Clinic, Tokyo, Japan. · Heishinaki Medical Group Incorporated OCROM Clinic, Osaka, Japan. · Daiwa Hospital, Osaka, Japan. · PCSK9 Development and Launch Unit, Sanofi, Montpellier, France. · Pubmed 27184170
2011
2008
  • Occupational Health Department, Sony Corporation, Tokyo, Japan. · Pubmed 18756039
University of Tokyo
2012
  • Teikyo University School of Medicine, Department of Internal Medicine, 2-11-1 Kaga Itabashi-ku, Tokyo 173-8605, Japan. · Pubmed 22332608
2011
  • Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 21921414
2010
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 20201733
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 20543522
2008
  • Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. · Pubmed 18762707
2009
  • Department of Neurology, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. · Pubmed 19423132
2008
  • Department of Internal Medicine, Jikei University School of Medicine 3-25-8, Nishi-Shimbashi, Minato-ku, 105-8461 Tokyo, Japan. · Pubmed 18635188
7 Other Locations Show
Yearly article counts 051020233240
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.